•
Dec 31, 2022

Beam Therapeutics Q4 2022 Earnings Report

Total Revenue
$20M
Previous year: $51.1M
-60.8%
EPS
-$0.54
Previous year: -$0.95
-43.2%
Gross Profit
$13.9M
Previous year: $46.1M
-69.9%
Cash and Equivalents
$233M
Previous year: $966M
-75.9%
Free Cash Flow
-$77.5M
Previous year: -$11.5M
+571.2%
Total Assets
$1.34B
Previous year: $1.47B
-9.0%

Beam Therapeutics

Beam Therapeutics